Product Reports Resources Pricing Login Book a demo

Anacor Pharmaceutical

Biotech & Life Sciences · Palo Alto, United States · Founded 2000 · IPO 2010

Biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform MoreLess

Anacor.com is a dynamic startup focused on revolutionizing the healthcare industry by providing comprehensive health management solutions. The company operates in the digital health market, catering to a diverse range of clients including individuals, caregivers, and healthcare professionals. Anacor.com offers a suite of services designed to help users manage their health effectively. These services include tools for tracking personal health metrics, managing medications, evaluating health information, and finding the right healthcare providers.

The business model of Anacor.com is primarily subscription-based, where users pay a recurring fee to access premium features and personalized health insights. Additionally, the company generates revenue through partnerships with healthcare providers and pharmaceutical companies, offering them a platform to reach and engage with potential patients.

Anacor.com stands out in the market by emphasizing health literacy and wellness. The platform provides educational resources on various health topics such as cardiovascular health, mental health, nutrition, and fitness. This focus on education empowers users to make informed decisions about their health.

The company also keeps its users updated with the latest news in the healthcare sector, including advancements in vaccine development and corporate performance updates from major pharmaceutical companies like Pfizer and BioNTech. This feature ensures that users are well-informed about significant developments that could impact their health and well-being.

In summary, Anacor.com is a forward-thinking startup that leverages technology to provide valuable health management tools and information. By focusing on user education and personalized health tracking, the company aims to improve overall health outcomes for its clients.

Keywords: digital health, health management, subscription-based, health literacy, wellness, personalized health, healthcare providers, pharmaceutical partnerships, health education, health tracking.

Valuation $5–10B
Revenue $50–100M
Headcount <100
Total funding $100–500M

Talent graph

Anacor Pharmaceutical's talent

Book a demo to see the people
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Anacor Pharmaceutical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
U.S. Department of the Treasury
Series A 3 investors entered at this stage
Rho Capital Partners
Aberdare Ventures
Rho Ventures
Series B+ 6 investors entered at this stage
Venrock
Care Capital
Red Abbey Venture Partners
Schering
GSK
Hercules Capital

Global footprint

Where Anacor Pharmaceutical has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States90.9%
🏳️ Mauritania9.1%
2 countries shown

Patent intelligence

$115M patent portfolio · 37 active families

Estimated portfolio value
$115M
2.2% of market cap · comparable to top peer Advanced Accelerator Applications ($86M)
37 active patent families
Where Anacor Pharmaceutical innovates Chemical compoundCombinatorial chemistryMedicinal chemistryMedicineMicrobiology

Where Anacor Pharmaceutical concentrates vs peers

Each axis is a top-10 topic across Anacor Pharmaceutical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Anacor Pharmaceutical

An AI-synthesized read of the highest-engagement posts about Anacor Pharmaceutical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Anacor Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.